Insilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
22/06/2026 07:13
BUZZ-Insilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up ** Shares of Insilico Medicine Cayman TopCo 3696.HK jump 8.5% to HK$41.58, their highest point since June 1
** On track for a third straight session of gain
** AI developer in pharmaceuticals enters into research and development collaboration with SK Biopharmaceuticals 326030.KS to discover AI-enabled innovative drug candidates in neuroimmune area of central nervous system
** Says it will be eligible to receive up to $18 mln in upfront and near-term milestone payments and total potential deal value exceeds $2.5 bln, including development, regulatory, and commercial milestone payments
** YTD, stock up 9.3%, while the Hang Seng Biotech Index .HSBIO down 16.6%
(Reporting by Donny Kwok)
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7